Trial
NCT03344172
Pre-Operative Trial (PGHA vs. PGH) for Resectable Pancreatic Cancer
Phase IITERMINATEDSAFETYConfidence: HIGH
Sponsor
Nathan Bahary, MD
Collaborators
Pfizer; National Cancer Institute (NCI)
Condition
Pancreatic Cancer Resectable
Intervention
Gemcitabine, Nab-Paclitaxel, hydroxychloroquine and Avelumab
Why stopped
Suspected Serious Adverse Events related to treatment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-05-14